{
event: "article_read",
name: `Blood esinophils, FeNO, and the modifiable risk of asthma attacks`,
author: ``,
tags: `Luftveiene | Astma`,
publication_date: ``,
interaction_type: "content"
}
Blood esinophils, FeNO, and the modifiable risk of asthma attacks
Recorded webinar
In Sanofi’s RespTalks webinar in January, Professor Ian Pavord & Dr. Simon Couillard discussed the concept of treatable traits as a new approach to managing asthma. In this recording, we hear Dr. Couillard presenting his views on how the treatable traits approach can aid the management of severe asthma.
Speaker: Simon Couillard, MD
Simon Couillard, MD, is a Canadian specialist in respiratory medicine and a clinical teacher at the Université de Sherbooke. He finished a two-year clinical research fellowship in severe asthma with the University of Oxford under the supervision of Professor Pavord, and has started a joint Oxford-Leiden PhD on risk prediction in asthma.
Denne nettsiden inneholder informasjon som er kun for helsepersonell som lege, tannlege, offentlig godkjent sykepleier, farmasøyt, optiker, tannpleier, samt studenter i disse fag.
